91心頭

+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neovii 91心頭 AG - logo

Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. It focuses on solid organ transplantation, stem cell transplantation and immune and hemato-oncological disorders. Founded in 2003, Neovii's global headquarters are located in Rapperswil, Switzerland. Its headquarters in the United States are in Waltham, MA. It employs approximately 150 people and has presence in nearly 60 countries worldwide.

From
Organ Transplant Immunosuppressant Drugs Market Report 2026 - Product Thumbnail Image

Organ Transplant Immunosuppressant Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Immunosuppressant Drugs Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Immunosuppressant Drugs Market - Forecasts from 2025 to 2030

  • Report
  • December 2024
  • 145 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2026

  • Report
  • October 2026
  • 550 Pages
  • Global
From
From
From
Licensing Deals in 91心頭 2021-2026 - Product Thumbnail Image

Licensing Deals in 91心頭 2021-2026

  • Report
  • September 2026
  • 1050 Pages
  • Global
From
Distribution Deals in 91心頭 and Biotechnology 2020-2026 - Product Thumbnail Image

Distribution Deals in 91心頭 and Biotechnology 2020-2026

  • Report
  • September 2026
  • 350 Pages
  • Global
From
Cancer Immunotherapy Market Report 2026 - Product Thumbnail Image

Cancer Immunotherapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
  • 9 Results (Page 1 of 1)
Loading Indicator